Table 5. Cardiovascular medication use at study enrollment, n (%).
| Medication | Total CTD (n = 436) | CTD without cardiovascular involvement (n = 154) | CTD with cardiovascular involvement (n = 282) | p value |
|---|---|---|---|---|
| Aspirin | 187 (42.9) | 71 (46.1) | 116 (41.1) | 0.316 |
| Statins | 70 (16.1) | 20 (13.0) | 50 (17.7) | 0.197 |
| Beta blockers | 16 (3.6) | 4 (2.6) | 12 (4.3) | 0.379 |
| ACEI/ARB | 55 (12.6) | 12 (7.8) | 43 (15.2) | 0.025 |
| Calcium ion antagonist | 103 (23.6) | 25 (16.2) | 78 (27.7) | 0.007 |
ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; CTD: connective tissue disease.